A citation-based method for searching scientific literature

Mads Agervig Tarp, Henrik Clausen. Biochim Biophys Acta 2008
Times Cited: 208







List of co-cited articles
999 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
Eric P Bennett, Ulla Mandel, Henrik Clausen, Thomas A Gerken, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2012
440
28

Mucins in cancer: protection and control of the cell surface.
Michael A Hollingsworth, Benjamin J Swanson. Nat Rev Cancer 2004
20



All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.
Kelly G Ten Hagen, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2003
340
16


Location, location, location: new insights into O-GalNAc protein glycosylation.
David J Gill, Henrik Clausen, Frederic Bard. Trends Cell Biol 2011
144
15

Immature truncated O-glycophenotype of cancer directly induces oncogenic features.
Prakash Radhakrishnan, Sally Dabelsteen, Frey Brus Madsen, Chiara Francavilla, Katharina L Kopp, Catharina Steentoft, Sergey Y Vakhrushev, Jesper V Olsen, Lars Hansen, Eric P Bennett,[...]. Proc Natl Acad Sci U S A 2014
160
15

Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc.
Tongzhong Ju, Grainger S Lanneau, Tripti Gautam, Yingchun Wang, Baoyun Xia, Sean R Stowell, Margaret T Willard, Wenyi Wang, Jonathan Y Xia, Rosemary E Zuna,[...]. Cancer Res 2008
174
14


Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology.
Catharina Steentoft, Sergey Y Vakhrushev, Hiren J Joshi, Yun Kong, Malene B Vester-Christensen, Katrine T-B G Schjoldager, Kirstine Lavrsen, Sally Dabelsteen, Nis B Pedersen, Lara Marcos-Silva,[...]. EMBO J 2013
718
14

The Tn antigen-structural simplicity and biological complexity.
Tongzhong Ju, Vivianne I Otto, Richard D Cummings. Angew Chem Int Ed Engl 2011
200
13

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine.
Vani Lakshminarayanan, Pamela Thompson, Margreet A Wolfert, Therese Buskas, Judy M Bradley, Latha B Pathangey, Cathy S Madsen, Peter A Cohen, Sandra J Gendler, Geert-Jan Boons. Proc Natl Acad Sci U S A 2012
196
13

Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
Jae-Hyun Park, Toshihiko Nishidate, Kyoko Kijima, Takao Ohashi, Kaoru Takegawa, Tomoko Fujikane, Koichi Hirata, Yusuke Nakamura, Toyomasa Katagiri. Cancer Res 2010
117
12


Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
Jae-Hyun Park, Toyomasa Katagiri, Suyoun Chung, Kyoko Kijima, Yusuke Nakamura. Neoplasia 2011
72
16

Glycans in cancer and inflammation--potential for therapeutics and diagnostics.
Danielle H Dube, Carolyn R Bertozzi. Nat Rev Drug Discov 2005
12

Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes.
Hans H Wandall, Ola Blixt, Mads A Tarp, Johannes W Pedersen, Eric P Bennett, Ulla Mandel, Govind Ragupathi, Phil O Livingston, Michael A Hollingsworth, Joyce Taylor-Papadimitriou,[...]. Cancer Res 2010
172
11


Glycosylation in cancer: mechanisms and clinical implications.
Salomé S Pinho, Celso A Reis. Nat Rev Cancer 2015
11

Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.
Avery D Posey, Robert D Schwab, Alina C Boesteanu, Catharina Steentoft, Ulla Mandel, Boris Engels, Jennifer D Stone, Thomas D Madsen, Karin Schreiber, Kathleen M Haines,[...]. Immunity 2016
262
11

Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3.
H H Wandall, H Hassan, E Mirgorodskaya, A K Kristensen, P Roepstorff, E P Bennett, P A Nielsen, M A Hollingsworth, J Burchell, J Taylor-Papadimitriou,[...]. J Biol Chem 1997
240
10

A mutant chaperone converts a wild-type protein into a tumor-specific antigen.
Andrea Schietinger, Mary Philip, Barbara A Yoshida, Parastoo Azadi, Hui Liu, Stephen C Meredith, Hans Schreiber. Science 2006
108
10

Glycosylation in cellular mechanisms of health and disease.
Kazuaki Ohtsubo, Jamey D Marth. Cell 2006
10

N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.
Chen Wu, Xiaodan Guo, Weina Wang, Yun Wang, Yaojun Shan, Bo Zhang, Wenqian Song, Sisi Ma, Jianfeng Ge, Hao Deng,[...]. BMC Cancer 2010
45
22

Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes.
David J Gill, Joanne Chia, Jamie Senewiratne, Frederic Bard. J Cell Biol 2010
137
10

Protein glycosylation: chaperone mutation in Tn syndrome.
Tongzhong Ju, Richard D Cummings. Nature 2005
187
9

The sweet and sour of cancer: glycans as novel therapeutic targets.
Mark M Fuster, Jeffrey D Esko. Nat Rev Cancer 2005
881
9

Structure and function of the cell surface (tethered) mucins.
Christine L Hattrup, Sandra J Gendler. Annu Rev Physiol 2008
430
9

Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival.
Z Li, S Yamada, S Inenaga, T Imamura, Y Wu, K-Y Wang, S Shimajiri, R Nakano, H Izumi, K Kohno,[...]. Br J Cancer 2011
55
16

UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.
Nora Berois, Daniel Mazal, Luis Ubillos, Felipe Trajtenberg, André Nicolas, Xavier Sastre-Garau, Henri Magdelenat, Eduardo Osinaga. J Histochem Cytochem 2006
56
16



Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
Klaus W Wagner, Elizabeth A Punnoose, Thomas Januario, David A Lawrence, Robert M Pitti, Kate Lancaster, Dori Lee, Melissa von Goetz, Sharon Fong Yee, Klara Totpal,[...]. Nat Med 2007
427
8

Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer.
S H Itzkowitz, M Yuan, C K Montgomery, T Kjeldsen, H K Takahashi, W L Bigbee, Y S Kim. Cancer Res 1989
484
8

Glycosylation defining cancer malignancy: new wine in an old bottle.
Senitiroh Hakomori. Proc Natl Acad Sci U S A 2002
706
8

MUC1 and cancer.
J Taylor-Papadimitriou, J Burchell, D W Miles, M Dalziel. Biochim Biophys Acta 1999
356
8

Vertebrate protein glycosylation: diversity, synthesis and function.
Kelley W Moremen, Michael Tiemeyer, Alison V Nairn. Nat Rev Mol Cell Biol 2012
861
8

Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer.
David Miles, Henri Roché, Miguel Martin, Timothy J Perren, David A Cameron, John Glaspy, David Dodwell, Joanne Parker, José Mayordomo, Alejandro Tres,[...]. Oncologist 2011
151
8

Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
Mads A Tarp, Anne Louise Sørensen, Ulla Mandel, Hans Paulsen, Joy Burchell, Joyce Taylor-Papadimitriou, Henrik Clausen. Glycobiology 2007
129
8

Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
K Taniuchi, R L Cerny, A Tanouchi, K Kohno, N Kotani, K Honke, T Saibara, M A Hollingsworth. Oncogene 2011
60
13

Mucin-type O-glycosylation during development.
Duy T Tran, Kelly G Ten Hagen. J Biol Chem 2013
146
8

The development of synthetic antitumour vaccines from mucin glycopeptide antigens.
Nikola Gaidzik, Ulrika Westerlind, Horst Kunz. Chem Soc Rev 2013
121
8

Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases.
Thomas A Gerken, Oliver Jamison, Cynthia L Perrine, Jeremy C Collette, Helen Moinova, Lakshmeswari Ravi, Sanford D Markowitz, Wei Shen, Himatkumar Patel, Lawrence A Tabak. J Biol Chem 2011
102
8

Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis.
Yun Kong, Hiren J Joshi, Katrine Ter-Borch Gram Schjoldager, Thomas Daugbjerg Madsen, Thomas A Gerken, Malene B Vester-Christensen, Hans H Wandall, Eric Paul Bennett, Steven B Levery, Sergey Y Vakhrushev,[...]. Glycobiology 2015
68
11

Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
Anne Louise Sørensen, Celso A Reis, Mads A Tarp, Ulla Mandel, Kavitha Ramachandran, Vasanthi Sankaranarayanan, Tilo Schwientek, Ros Graham, Joyce Taylor-Papadimitriou, Michael A Hollingsworth,[...]. Glycobiology 2006
172
8

Altered tumor-cell glycosylation promotes metastasis.
Irina Häuselmann, Lubor Borsig. Front Oncol 2014
219
8

The tumour glyco-code as a novel immune checkpoint for immunotherapy.
Ernesto RodrÍguez, Sjoerd T T Schetters, Yvette van Kooyk. Nat Rev Immunol 2018
131
8

Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion.
Lu-Gang Yu, Nigel Andrews, Qicheng Zhao, Daniel McKean, Jennifer F Williams, Lucy J Connor, Oleg V Gerasimenko, John Hilkens, Jun Hirabayashi, Kenichi Kasai,[...]. J Biol Chem 2007
208
7

The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
Robert Sewell, Malin Bäckström, Martin Dalziel, Steven Gschmeissner, Hasse Karlsson, Thomas Noll, Jochem Gätgens, Henrik Clausen, Gunnar C Hansson, Joy Burchell,[...]. J Biol Chem 2006
144
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.